Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Study To Evaluate The Effects Of DP-b99 On Neurologic Function And Disability In Subjects With Acute Ischemic Hemispheric Stroke

NCT00190047 is registered in ClinicalTrials.gov with D-Pharm Ltd. as lead sponsor.

NCT NCT00190047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00190047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Study To Evaluate The Effects Of DP-b99 On Neurologic Function And Disability In Subjects With Acute Ischemic Hemispheric Stroke
Lead sponsor
D-Pharm Ltd.
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2005
Completion date
October 31, 2006
Enrollment
150
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

brain ischemia, cerebrovascular disorders, stroke